{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T18:41:51Z","timestamp":1767724911039,"version":"build-2238731810"},"publisher-location":"Cham","reference-count":126,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032099808","type":"print"},{"value":"9783032099815","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/82_2025_294","type":"book-chapter","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T12:35:48Z","timestamp":1747139748000},"page":"149-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dengue Dilemma: Navigating Cross-Reactivity and Immune Challenges"],"prefix":"10.1007","author":[{"given":"Cristina R.","family":"de Barros Cardoso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago","family":"Cerqueira-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoel","family":"Barral-Netto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane S.","family":"Boaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"294_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00610-21","volume":"95","author":"C Aggarwal","year":"2021","unstructured":"Aggarwal C, Saini K, Reddy ES, Singla M, Nayak K, Chawla YM, Maheshwari D, Singh P, Sharma P, Bhatnagar P, Kumar S, Gottimukkala K, Panda H, Gunisetty S, Davis CW, Kissick HT, Kabra SK, Lodha R, Medigeshi GR, Ahmed R, Murali-Krishna K, Chandele A (2021) Immunophenotyping and transcriptional profiling of human plasmablasts in dengue. J Virol 95:e0061021. https:\/\/doi.org\/10.1128\/JVI.00610-21","journal-title":"J Virol"},{"key":"294_CR2","doi-asserted-by":"publisher","first-page":"9395","DOI":"10.1038\/s41598-019-45816-6","volume":"9","author":"R Aguas","year":"2019","unstructured":"Aguas R, Dorigatti I, Coudeville L, Luxemburger C, Ferguson NM (2019) Cross-serotype interactions and disease outcome prediction of dengue infections in Vietnam. Sci Rep 9:9395. https:\/\/doi.org\/10.1038\/s41598-019-45816-6","journal-title":"Sci Rep"},{"key":"294_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/infdis\/jit436","volume":"209","author":"KB Anderson","year":"2014","unstructured":"Anderson KB, Gibbons RV, Cummings DAT, Nisalak A, Green S, Libraty DH, Jarman RG, Srikiatkhachorn A, Mammen MP, Darunee B, Yoon I-K, Endy TP (2014) A Shorter Time Interval Between First and Second Dengue Infections Is Associated With Protection From Clinical Illness in a School-based Cohort in Thailand. J Infect Dis 209:360\u2013368. https:\/\/doi.org\/10.1093\/infdis\/jit436","journal-title":"J Infect Dis"},{"key":"294_CR4","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/infdis\/jiaa120","volume":"222","author":"P Andrade","year":"2020","unstructured":"Andrade P, Narvekar P, Montoya M, Michlmayr D, Balmaseda A, Coloma J, Harris E (2020) Primary and secondary dengue virus infections elicit similar memory B-cell responses, but breadth to other serotypes and cross-reactivity to Zika virus is higher in secondary dengue. J Infect Dis 222:590\u2013600. https:\/\/doi.org\/10.1093\/infdis\/jiaa120","journal-title":"J Infect Dis"},{"key":"294_CR5","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1038\/s41418-019-0313-x","volume":"26","author":"D Aprile","year":"2019","unstructured":"Aprile D, Fruscione F, Baldassari S, Fadda M, Ferrante D, Falace A, Buhler E, Sartorelli J, Represa A, Baldelli P, Benfenati F, Zara F, Fassio A (2019) TBC1D24 regulates axonal outgrowth and membrane trafficking at the growth cone in rodent and human neurons. Cell Death Differ 26:2464\u20132478. https:\/\/doi.org\/10.1038\/s41418-019-0313-x","journal-title":"Cell Death Differ"},{"key":"294_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40794-024-00231-2","volume":"10","author":"DG Aynekulu Mersha","year":"2024","unstructured":"Aynekulu Mersha DG, van der Sterren I, van Leeuwen LPM, Langerak T, Hakim MS, Martina B, van Lelyveld SFL, van Gorp ECM (2024) The role of antibody-dependent enhancement in dengue vaccination. Trop Dis Travel Med Vacc 10:22. https:\/\/doi.org\/10.1186\/s40794-024-00231-2","journal-title":"Trop Dis Travel Med Vacc"},{"key":"294_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1126\/science.1519064","volume":"257","author":"SM Bajjalieh","year":"1992","unstructured":"Bajjalieh SM, Peterson K, Shinghal R, Scheller RH (1992) SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science 257:1271\u20131273. https:\/\/doi.org\/10.1126\/science.1519064","journal-title":"Science"},{"key":"294_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029430","volume":"6","author":"T Balakrishnan","year":"2011","unstructured":"Balakrishnan T, Bela-Ong DB, Toh YX, Flamand M, Devi S, Koh MB, Hibberd ML, Ooi EE, Low JG, Leo YS, Gu F, Fink K (2011) Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. PLoS One 6:e29430. https:\/\/doi.org\/10.1371\/journal.pone.0029430","journal-title":"PLoS One"},{"key":"294_CR9","doi-asserted-by":"publisher","first-page":"8384","DOI":"10.1073\/pnas.1704984114","volume":"114","author":"A Balmaseda","year":"2017","unstructured":"Balmaseda A, Stettler K, Medialdea-Carrera R, Collado D, Jin X, Zambrana JV, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira P, Brown DWG, Baldanti F, Tedder R, Zambon M, de Filippis AMB, Harris E, Corti D (2017) Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci 114:8384\u20138389. https:\/\/doi.org\/10.1073\/pnas.1704984114","journal-title":"Proc Natl Acad Sci"},{"key":"294_CR125","doi-asserted-by":"publisher","unstructured":"Balmaseda A, Zambrana JV, Collado D, Garc\u00eda N, Sabor\u00edo S, Elizondo D, Mercado JC, Gonzalez K, Cerpas C, Nu\u00f1ez A, Corti D, Waggoner JJ, Kuan G, Burger-Calderon R, Harris E (2018) Comparison of four serological methods and two reverse transcription-PCR assays for diagnosis and surveillance of Zika virus infection. J Clin Microbiol 56(3). https:\/\/doi.org\/10.1128\/JCM.01785-17","DOI":"10.1128\/JCM.01785-17"},{"key":"294_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000790","volume":"6","author":"SJ Balsitis","year":"2010","unstructured":"Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E (2010) Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6:e1000790. https:\/\/doi.org\/10.1371\/journal.ppat.1000790","journal-title":"PLoS Pathog"},{"key":"294_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","volume":"536","author":"G Barba-Spaeth","year":"2016","unstructured":"Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney M-C, Medits I, Sharma A, Simon-Lori\u00e8re E, Sakuntabhai A, Cao-Lormeau V-M, Haouz A, England P, Stiasny K, Mongkolsapaya J, Heinz FX, Screaton GR, Rey FA (2016) Structural basis of potent Zika\u2013dengue virus antibody cross-neutralization. Nature 536:48\u201353. https:\/\/doi.org\/10.1038\/nature18938","journal-title":"Nature"},{"key":"294_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/vim.2010.0034","volume":"23","author":"CM Beaumier","year":"2010","unstructured":"Beaumier CM, Jaiswal S, West KY, Friberg H, Mathew A, Rothman AL (2010) Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells. Viral Immunol 23:477\u2013485. https:\/\/doi.org\/10.1089\/vim.2010.0034","journal-title":"Viral Immunol"},{"key":"294_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01582-24","volume":"98","author":"L Belmont","year":"2024","unstructured":"Belmont L, Contreras M, Cartwright-Acar CH, Marceau CD, Agrawal A, Levoir LM, Lubow J, Goo L (2024) Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection. J Virol 98:e0158224. https:\/\/doi.org\/10.1128\/jvi.01582-24","journal-title":"J Virol"},{"key":"294_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005194","volume":"12","author":"R Ben-Shachar","year":"2016","unstructured":"Ben-Shachar R, Schmidler S, Koelle K (2016) Drivers of inter-individual variation in dengue viral load dynamics. PLoS Comput Biol 12:e1005194. https:\/\/doi.org\/10.1371\/journal.pcbi.1005194","journal-title":"PLoS Comput Biol"},{"key":"294_CR15","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0140-6736(20)30414-1","volume":"395","author":"S Biswal","year":"2020","unstructured":"Biswal S, Borja-Tabora C, Martinez Vargas L, Vel\u00e1squez H, Theresa Alera M, Sierra V, Johana Rodriguez-Arenales E, Yu D, Wickramasinghe VP, Duarte Moreira E, Fernando AD, Gunasekera D, Kosalaraksa P, Espinoza F, L\u00f3pez-Medina E, Bravo L, Tuboi S, Hutagalung Y, Garbes P, Escudero I, Rauscher M, Bizjajeva S, LeFevre I, Borkowski A, Saez-Llorens X, Wallace D, TIDES Study Group (2020) Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial. Lancet 395:1423\u20131433. https:\/\/doi.org\/10.1016\/S0140-6736(20)30414-1","journal-title":"Lancet"},{"key":"294_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/cid\/ciae369","volume":"80","author":"C Borja-Tabora","year":"2024","unstructured":"Borja-Tabora C, Fernando L, Lopez Medina E, Reynales H, Rivera L, Saez-Llorens X, Sirivichayakul C, Yu D, Folschweiller N, Moss KJ, Rauscher M, Tricou V, Zhao Y, Biswal S (2024) Immunogenicity, safety, and efficacy of a tetravalent dengue vaccine in children and adolescents: an analysis by age group. Clin Infect Dis 80:199. https:\/\/doi.org\/10.1093\/cid\/ciae369","journal-title":"Clin Infect Dis"},{"key":"294_CR17","doi-asserted-by":"publisher","first-page":"eaan1589","DOI":"10.1126\/scitranslmed.aan1589","volume":"9","author":"I Bosch","year":"2017","unstructured":"Bosch I, de Puig H, Hiley M, Carr\u00e9-Camps M, Perdomo-Celis F, Narv\u00e1ez CF, Salgado DM, Senthoor D, O\u2019Grady M, Phillips E, Durbin A, Fandos D, Miyazaki H, Yen C-W, G\u00e9lvez-Ram\u00edrez M, Warke RV, Ribeiro LS, Teixeira MM, Almeida RP, Mu\u00f1\u00f3z-Medina JE, Ludert JE, Nogueira ML, Colombo TE, Terzian ACB, Bozza PT, Calheiros AS, Vieira YR, Barbosa-Lima G, Vizzoni A, Cerbino-Neto J, Bozza FA, Souza TML, Trugilho MRO, de Filippis AMB, de Sequeira PC, Marques ETA, Magalhaes T, D\u00edaz FJ, Restrepo BN, Mar\u00edn K, Mattar S, Olson D, Asturias EJ, Lucera M, Singla M, Medigeshi GR, de Bosch N, Tam J, G\u00f3mez-M\u00e1rquez J, Clavet C, Villar L, Hamad-Schifferli K, Gehrke L (2017) Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. Sci Transl Med 9:eaan1589. https:\/\/doi.org\/10.1126\/scitranslmed.aan1589","journal-title":"Sci Transl Med"},{"key":"294_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1099\/vir.0.82537-0","volume":"88","author":"T Chareonsirisuthigul","year":"2007","unstructured":"Chareonsirisuthigul T, Kalayanarooj S, Ubol S (2007) Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol 88:365\u2013375. https:\/\/doi.org\/10.1099\/vir.0.82537-0","journal-title":"J Gen Virol"},{"key":"294_CR19","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/infdis\/jiv258","volume":"212","author":"H Chu","year":"2015","unstructured":"Chu H, George SL, Stinchcomb DT, Osorio JE, Partidos CD (2015) CD8+ T-cell responses in flavivirus-naive individuals following immunization with a live-attenuated tetravalent dengue vaccine candidate. J Infect Dis 212:1618\u20131628. https:\/\/doi.org\/10.1093\/infdis\/jiv258","journal-title":"J Infect Dis"},{"issue":"5","key":"294_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3201\/eid2305.161630","volume":"23","author":"MH Collins","year":"2017","unstructured":"Collins MH, McGowan E, Jadi R, Young E, Lopez CA, Baric RS et al (2017) Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection. Emerg Infect Dis 23(5):773","journal-title":"Emerg Infect Dis"},{"key":"294_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001188","volume":"5","author":"R de Alwis","year":"2011","unstructured":"de Alwis R, Beltramello M, Messer WB, Sukupolvi-Petty S, Wahala WMPB, Kraus A, Olivarez NP, Pham Q, Brian J, Tsai W-Y, Wang W-K, Halstead S, Kliks S, Diamond MS, Baric R, Lanzavecchia A, Sallusto F, de Silva AM (2011) In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis 5:e1188. https:\/\/doi.org\/10.1371\/journal.pntd.0001188","journal-title":"PLoS Negl Trop Dis"},{"key":"294_CR22","unstructured":"de la Salud AM (2017) Emergencias sanitarias: respuesta de la OMS a las emergencias graves a gran escala: informe de la Directora General"},{"key":"294_CR23","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","volume":"17","author":"W Dejnirattisai","year":"2016","unstructured":"Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, Sakuntabhai A, Cao-Lormeau V-M, Malasit P, Rey FA, Mongkolsapaya J, Screaton GR (2016) Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol 17:1102\u20131108. https:\/\/doi.org\/10.1038\/ni.3515","journal-title":"Nat Immunol"},{"key":"294_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007747","volume":"13","author":"J Denis","year":"2019","unstructured":"Denis J, Attoumani S, Gravier P, Tenebray B, Garnier A, Briolant S, de Laval F, Chastres V, Grard G, Leparc-Goffart I, Coutard B, Badaut C (2019) High specificity and sensitivity of Zika EDIII-based ELISA diagnosis highlighted by a large human reference panel. PLoS Negl Trop Dis 13:e0007747. https:\/\/doi.org\/10.1371\/journal.pntd.0007747","journal-title":"PLoS Negl Trop Dis"},{"key":"294_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12879-015-0877-0","volume":"15","author":"C Domingo","year":"2015","unstructured":"Domingo C, Alves MJ, de Ory F, Teichmann A, Schmitz H, M\u00fcller R, Niedrig M (2015) International external quality control assessment for the serological diagnosis of dengue infections. BMC Infect Dis 15:167. https:\/\/doi.org\/10.1186\/s12879-015-0877-0","journal-title":"BMC Infect Dis"},{"key":"294_CR26","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","volume":"360","author":"MR Duffy","year":"2009","unstructured":"Duffy MR et al (2009) Zika Virus Outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360:2536\u20132543. https:\/\/doi.org\/10.1056\/NEJMoa0805715","journal-title":"N Engl J Med"},{"key":"294_CR27","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/infdis\/jis936","volume":"207","author":"AP Durbin","year":"2013","unstructured":"Durbin AP, Kirkpatrick BD, Pierce KK, Elwood D, Larsson CJ, Lindow JC, Tibery C, Sabundayo BP, Shaffer D, Talaat KR, Hynes NA, Wanionek K, Carmolli MP, Luke CJ, Murphy BR, Subbarao K, Whitehead SS (2013) A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial. J Infect Dis 207:957\u2013965. https:\/\/doi.org\/10.1093\/infdis\/jis936","journal-title":"J Infect Dis"},{"key":"294_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/aje\/kwf005","volume":"156","author":"TP Endy","year":"2002","unstructured":"Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, Vaughn DW, Ennis FA (2002) Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 156:40\u201351. https:\/\/doi.org\/10.1093\/aje\/kwf005","journal-title":"Am J Epidemiol"},{"key":"294_CR29","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1086\/382280","volume":"189","author":"TP Endy","year":"2004","unstructured":"Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH (2004) Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189:990\u20131000. https:\/\/doi.org\/10.1086\/382280","journal-title":"J Infect Dis"},{"key":"294_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011710","volume":"17","author":"CF Estofolete","year":"2023","unstructured":"Estofolete CF, Versiani AF, Dourado FS, Milhim BHGA, Pacca CC, Silva GCD, Zini N, de Santos BF, Gandolfi FA, Mistr\u00e3o NFB, Garcia PHC, Rocha RS, Gehrke L, Bosch I, Marques RE, Teixeira MM, da Fonseca FG, Vasilakis N, Nogueira ML (2023) Influence of previous Zika virus infection on acute dengue episode. PLoS Negl Trop Dis 17:e0011710. https:\/\/doi.org\/10.1371\/journal.pntd.0011710","journal-title":"PLoS Negl Trop Dis"},{"key":"294_CR31","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ni.3849","volume":"18","author":"E Fernandez","year":"2017","unstructured":"Fernandez E, Dejnirattisai W, Cao B, Scheaffer SM, Supasa P, Wongwiwat W, Esakky P, Drury A, Mongkolsapaya J, Moley KH, Mysorekar IU, Screaton GR, Diamond MS (2017) Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection. Nat Immunol 18:1261\u20131269. https:\/\/doi.org\/10.1038\/ni.3849","journal-title":"Nat Immunol"},{"key":"294_CR32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.chom.2018.09.015","volume":"24","author":"AM Fowler","year":"2018","unstructured":"Fowler AM, Tang WW, Young MP, Mamidi A, Viramontes KM, McCauley MD, Carlin AF, Schooley RT, Swanstrom J, Baric RS, Govero J, Diamond MS, Shresta S (2018) Maternally acquired Zika antibodies enhance dengue disease severity in mice. Cell Host Microbe 24:743\u2013750. https:\/\/doi.org\/10.1016\/j.chom.2018.09.015","journal-title":"Cell Host Microbe"},{"key":"294_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000617","volume":"4","author":"JR Fried","year":"2010","unstructured":"Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon I-K, Jarman RG, Green S, Rothman AL, Cummings DAT (2010) Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4:e617. https:\/\/doi.org\/10.1371\/journal.pntd.0000617","journal-title":"PLoS Negl Trop Dis"},{"key":"294_CR34","doi-asserted-by":"publisher","unstructured":"Gaspar-Castillo C, Rodr\u00edguez MH, Ortiz-Navarrete V, Alpuche-Aranda CM, Martinez-Barnetche J (2023) Structural and immunological basis of cross-reactivity between dengue and Zika infections: Implications in serosurveillance in endemic regions. Front Microbiol 14. https:\/\/doi.org\/10.3389\/fmicb.2023.1107496","DOI":"10.3389\/fmicb.2023.1107496"},{"key":"294_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012683","volume":"20","author":"C Gebo","year":"2024","unstructured":"Gebo C, Hardy CSC, McElvany BD, Graham NR, Lu JQ, Moradpour S, Currier JR, Friberg H, Gromowski GD, Thomas SJ, Chan GC, Diehl SA, Waickman AT (2024) B cell receptor dependent enhancement of dengue virus infection. PLoS Pathog 20:e1012683. https:\/\/doi.org\/10.1371\/journal.ppat.1012683","journal-title":"PLoS Pathog"},{"key":"294_CR36","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.1038\/s41598-017-10901-1","volume":"7","author":"J George","year":"2017","unstructured":"George J, Valiant WG, Mattapallil MJ, Walker M, Huang Y-JS, Vanlandingham DL, Misamore J, Greenhouse J, Weiss DE, Verthelyi D, Higgs S, Andersen H, Lewis MG, Mattapallil JJ (2017) Prior exposure to Zika virus significantly enhances peak dengue-2 viremia in rhesus macaques. Sci Rep 7:10498. https:\/\/doi.org\/10.1038\/s41598-017-10901-1","journal-title":"Sci Rep"},{"key":"294_CR37","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1038\/s41590-023-01654-3","volume":"24","author":"L Ghita","year":"2023","unstructured":"Ghita L, Yao Z, Xie Y, Duran V, Cagirici HB, Samir J, Osman I, Rebell\u00f3n-S\u00e1nchez DE, Agudelo-Rojas OL, Sanz AM, Sahoo MK, Robinson ML, Gelvez-Ramirez RM, Bueno N, Luciani F, Pinsky BA, Montoya JG, Estupi\u00f1an-Cardenas MI, Villar-Centeno LA, Rojas-Garrido EM, Rosso F, Quake SR, Zanini F, Einav S (2023) Global and cell type-specific immunological hallmarks of severe dengue progression identified via a systems immunology approach. Nat Immunol 24:2150\u20132163. https:\/\/doi.org\/10.1038\/s41590-023-01654-3","journal-title":"Nat Immunol"},{"key":"294_CR38","doi-asserted-by":"publisher","first-page":"910","DOI":"10.4269\/ajtmh.2007.77.910","volume":"77","author":"RV Gibbons","year":"2007","unstructured":"Gibbons RV, Kalanarooj S, Jarman RG, Nisalak A, Vaughn DW, Endy TP, Mammen MP, Srikiatkhachorn A (2007) Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg 77:910\u2013913","journal-title":"Am J Trop Med Hyg"},{"key":"294_CR39","doi-asserted-by":"publisher","first-page":"9422","DOI":"10.1073\/pnas.0703498104","volume":"104","author":"AP Goncalvez","year":"2007","unstructured":"Goncalvez AP, Engle RE et al (2007) Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci 104:9422\u20139427. https:\/\/doi.org\/10.1073\/pnas.0703498104","journal-title":"Proc Natl Acad Sci"},{"key":"294_CR40","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1086\/314680","volume":"179","author":"S Green","year":"1999","unstructured":"Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA (1999) Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179:755\u2013762. https:\/\/doi.org\/10.1086\/314680","journal-title":"J Infect Dis"},{"key":"294_CR41","doi-asserted-by":"publisher","first-page":"e01469","DOI":"10.1128\/JVI.01469-17","volume":"91","author":"A Grifoni","year":"2017","unstructured":"Grifoni A, Pham J, Sidney J, O\u2019Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR et al (2017) Prior dengue virus exposure shapes T cell immunity to Zika virus in humans. J Virol 91:e01469\u2013e01417. https:\/\/doi.org\/10.1128\/JVI.01469-17","journal-title":"J Virol"},{"key":"294_CR42","doi-asserted-by":"publisher","first-page":"e00089","DOI":"10.1128\/JVI.00089-20","volume":"94","author":"A Grifoni","year":"2020","unstructured":"Grifoni A, Voic H, Dhanda SK, Kidd CK, Brien JD, Buus S, Stryhn A, Durbin AP, Whitehead S, Diehl SA, De Silva AD, Balmaseda A, Harris E, Weiskopf D, Sette A (2020) T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species. J Virol 94:e00089\u2013e00020. https:\/\/doi.org\/10.1128\/JVI.00089-20","journal-title":"J Virol"},{"key":"294_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1590\/S1020-49892002000400003","volume":"11","author":"MG Guzm\u00e1n","year":"2002","unstructured":"Guzm\u00e1n MG, Kour\u00ed G, Vald\u00e9s L, Bravo J, V\u00e1zquez S, Halstead SB (2002) Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica 11:223\u2013227","journal-title":"Rev Panam Salud Publica"},{"key":"294_CR44","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro SR, Arredondo-Garc\u00eda JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Ismail HIHM, Reynales H, Limkittikul K, Rivera-Medina DM, Tran HN, Bouckenooghe A, Chansinghakul D, Cort\u00e9s M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M (2015) Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med 373:1195\u20131206. https:\/\/doi.org\/10.1056\/NEJMoa1506223","journal-title":"N Engl J Med"},{"key":"294_CR45","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.3277268","volume":"239","author":"SB Halstead","year":"1988","unstructured":"Halstead SB (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239:476\u2013481. https:\/\/doi.org\/10.1126\/science.3277268","journal-title":"Science"},{"key":"294_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/s0065-3527(03)60011-4","volume":"60","author":"SB Halstead","year":"2003","unstructured":"Halstead SB (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60:421\u2013467. https:\/\/doi.org\/10.1016\/s0065-3527(03)60011-4","journal-title":"Adv Virus Res"},{"key":"294_CR47","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.12688\/f1000research.7024.1","volume":"4","author":"SB Halstead","year":"2015","unstructured":"Halstead SB (2015) Pathogenesis of dengue: dawn of a new era. F1000Research 4:1353. https:\/\/doi.org\/10.12688\/f1000research.7024.1","journal-title":"F1000Research"},{"key":"294_CR48","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1016\/j.vaccine.2017.09.089","volume":"35","author":"SB Halstead","year":"2017","unstructured":"Halstead SB (2017) Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine 35:6355\u20136358. https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.089","journal-title":"Vaccine"},{"key":"294_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.146.1.201","volume":"146","author":"S Halstead","year":"1977","unstructured":"Halstead S, O\u2019Rourke E (1977) Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146:201\u2013217. https:\/\/doi.org\/10.1084\/jem.146.1.201","journal-title":"J Exp Med"},{"key":"294_CR50","first-page":"311","volume":"42","author":"SB Halstead","year":"1970","unstructured":"Halstead SB, Nimmannitya S, Cohen SN (1970) Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 42:311\u2013328","journal-title":"Yale J Biol Med"},{"key":"294_CR51","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3389\/fimmu.2019.01045","volume":"10","author":"M Hassert","year":"2019","unstructured":"Hassert M, Brien JD, Pinto AK (2019) Mouse models of heterologous flavivirus immunity: a role for cross-reactive T cells. Front Immunol 10:1045. https:\/\/doi.org\/10.3389\/fimmu.2019.01045","journal-title":"Front Immunol"},{"key":"294_CR52","doi-asserted-by":"publisher","unstructured":"Hein LD, Castillo IN, Medina FA, Vila F, Segovia-Chumbez B, Mu\u00f1oz-Jord\u00e1n JL, Whitehead SS, Adams LE, Paz-Bailey G, de Silva AM, Premkumar L (2024) Multiplex sample-sparing assay for detecting type-specific antibodies to Zika and dengue viruses: an assay development and validation study. Lancet Microbe 6. https:\/\/doi.org\/10.1016\/j.lanmic.2024.07.014","DOI":"10.1016\/j.lanmic.2024.07.014"},{"key":"294_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1743-422X-9-115","volume":"9","author":"HR Hughes","year":"2012","unstructured":"Hughes HR, Crill WD, Chang G-JJ (2012) Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement. Virol J 9:115. https:\/\/doi.org\/10.1186\/1743-422X-9-115","journal-title":"Virol J"},{"key":"294_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12985-018-0963-1","volume":"15","author":"L Jiang","year":"2018","unstructured":"Jiang L, Sun Q (2018) The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3. Virol J 15:50. https:\/\/doi.org\/10.1186\/s12985-018-0963-1","journal-title":"Virol J"},{"key":"294_CR55","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMoa2301790","volume":"390","author":"EG Kall\u00e1s","year":"2024","unstructured":"Kall\u00e1s EG, Cintra MAT, Moreira JA, Pati\u00f1o EG, Braga PE, Ten\u00f3rio JCV, Infante V, Palacios R, de Lacerda MVG, Pereira DB, da Fonseca AJ, Gurgel RQ, Coelho IC-B, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Barral AMP, Boaventura VS, Ramos F, J\u00fanior EE, de Moraes JC, Covas DT, Kalil J, Precioso AR, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee J-J, Macey J, Kelner SG, Coller B-AG, Boulos FC, Nogueira ML (2024) Live, attenuated, tetravalent butantan\u2013dengue vaccine in children and adults. N Engl J Med 390:397\u2013408. https:\/\/doi.org\/10.1056\/NEJMoa2301790","journal-title":"N Engl J Med"},{"key":"294_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003445","volume":"9","author":"Y-W Kam","year":"2015","unstructured":"Kam Y-W, Pok K-Y, Eng KE, Tan L-K, Kaur S, Lee WWL, Leo Y-S, Ng L-C, Ng LFP (2015) Sero-prevalence and cross-reactivity of chikungunya virus specific anti-E2EP3 antibodies in arbovirus-infected patients. PLoS Negl Trop Dis 9:e3445. https:\/\/doi.org\/10.1371\/journal.pntd.0003445","journal-title":"PLoS Negl Trop Dis"},{"key":"294_CR57","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1126\/science.aac5017","volume":"349","author":"LC Katzelnick","year":"2015","unstructured":"Katzelnick LC, Fonville JM, Gromowski GD, Arriaga JB, Green A, James SL, Lau L, Montoya M, Wang C, VanBlargan LA, Russell CA, Thu HM, Pierson TC, Buchy P, Aaskov JG, Mu\u00f1oz-Jord\u00e1n JL, Vasilakis N, Gibbons RV, Tesh RB, Osterhaus ADME, Fouchier RAM, Durbin A, Simmons CP, Holmes EC, Harris E, Whitehead SS, Smith DJ (2015) Dengue viruses cluster antigenically but not as discrete serotypes. Science 349:1338\u20131343. https:\/\/doi.org\/10.1126\/science.aac5017","journal-title":"Science"},{"key":"294_CR58","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E (2017) Antibody-dependent enhancement of severe dengue disease in humans. Science 358:929\u2013932. https:\/\/doi.org\/10.1126\/science.aan6836","journal-title":"Science"},{"key":"294_CR59","doi-asserted-by":"publisher","first-page":"eabg9478","DOI":"10.1126\/scitranslmed.abg9478","volume":"13","author":"LC Katzelnick","year":"2021","unstructured":"Katzelnick LC, Zambrana JV, Elizondo D, Collado D, Garcia N, Arguello S, Mercado JC, Miranda T, Ampie O, Mercado BL, Narvaez C, Gresh L, Binder RA, Ojeda S, Sanchez N, Plazaola M, Latta K, Schiller A, Coloma J, Carrillo FB, Narvaez F, Halloran ME, Gordon A, Kuan G, Balmaseda A, Harris E (2021) Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term. Sci Transl Med 13:eabg9478. https:\/\/doi.org\/10.1126\/scitranslmed.abg9478","journal-title":"Sci Transl Med"},{"key":"294_CR60","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/infdis\/jiv082","volume":"212","author":"BD Kirkpatrick","year":"2015","unstructured":"Kirkpatrick BD, Durbin AP, Pierce KK, Carmolli MP, Tibery CM, Grier PL, Hynes N, Diehl SA, Elwood D, Jarvis AP, Sabundayo BP, Lyon CE, Larsson CJ, Jo M, Lovchik JM, Luke CJ, Walsh MC, Fraser EA, Subbarao K, Whitehead SS (2015) Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults. J Infect Dis 212:702\u2013710. https:\/\/doi.org\/10.1093\/infdis\/jiv082","journal-title":"J Infect Dis"},{"key":"294_CR61","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","volume":"38","author":"SC Kliks","year":"1988","unstructured":"Kliks SC, Nimmanitya S, Nisalak A, Burke DS (1988) Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38:411\u2013419. https:\/\/doi.org\/10.4269\/ajtmh.1988.38.411","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"294_CR62","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3201\/eid1408.080287","volume":"14","author":"RS Lanciotti","year":"2008","unstructured":"Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ et al (2008) Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14(8):1232","journal-title":"Emerg Infect Dis"},{"key":"294_CR63","doi-asserted-by":"publisher","unstructured":"Lin T-H, Chen H-W, Hsiao Y-J, Yan J-Y, Chiang C-Y, Chen M-Y, Hu H-M, Wu S-H, Pan C-H (2020) Immunodomination of serotype-specific CD4+ T-cell epitopes contributed to the biased immune responses induced by a tetravalent measles-vectored dengue vaccine. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.00546","DOI":"10.3389\/fimmu.2020.00546"},{"key":"294_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tmaid.2019.05.002","volume":"30","author":"MJ Luppe","year":"2019","unstructured":"Luppe MJ, Verro AT, Barbosa AS, Nogueira ML, Undurraga EA, da Silva NS (2019) Yellow fever (YF) vaccination does not increase dengue severity: a retrospective study based on 11,448 dengue notifications in a YF and dengue endemic region. Travel Med Infect Dis 30:25\u201331. https:\/\/doi.org\/10.1016\/j.tmaid.2019.05.002","journal-title":"Travel Med Infect Dis"},{"key":"294_CR65","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/diagnostics10100835","volume":"10","author":"M Machado Portilho","year":"2020","unstructured":"Machado Portilho M, de Moraes L, Kikuti M, Jacob Nascimento LC, Galv\u00e3o Reis M, Sampaio Boaventura V, Khouri R, Sousa Ribeiro G (2020) Accuracy of the Zika IgM antibody capture enzyme-linked immunosorbent assay from the centers for disease control and prevention (CDC Zika MAC-ELISA) for diagnosis of Zika virus infection. Diagnostics 10:835. https:\/\/doi.org\/10.3390\/diagnostics10100835","journal-title":"Diagnostics"},{"key":"294_CR126","doi-asserted-by":"publisher","unstructured":"Medina FA et al. (2022) Capacity of a multiplex IgM antibody capture ELISA to differentiate Zika and dengue virus infections in areas of concurrent endemic transmission. Am J Trop Med Hyg 106(2):585\u2013592. https:\/\/doi.org\/10.4269\/ajtmh.20-1651","DOI":"10.4269\/ajtmh.20-1651"},{"key":"294_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104922","volume":"99","author":"A Miauton","year":"2024","unstructured":"Miauton A, Audran R, Besson J, Maby-El Hajjami H, Karlen M, Warpelin-Decrausaz L, Sene L, Schaufelberger S, Faivre V, Faouzi M, Hartley M-A, Spertini F, Genton B (2024) Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study. EBioMedicine 99:104922. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104922","journal-title":"EBioMedicine"},{"key":"294_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002357","volume":"7","author":"M Montoya","year":"2013","unstructured":"Montoya M, Gresh L, Mercado JC, Williams KL, Vargas MJ, Gutierrez G, Kuan G, Gordon A, Balmaseda A, Harris E (2013) Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis 7:e2357. https:\/\/doi.org\/10.1371\/journal.pntd.0002357","journal-title":"PLoS Negl Trop Dis"},{"key":"294_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004031","volume":"10","author":"JKW Ng","year":"2014","unstructured":"Ng JKW, Zhang SL, Tan HC, Yan B, Martinez JM, Tan WY, Lam JH, Tan GKX, Ooi EE, Alonso S (2014) First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies. PLoS Pathog 10:e1004031. https:\/\/doi.org\/10.1371\/journal.ppat.1004031","journal-title":"PLoS Pathog"},{"key":"294_CR69","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ebiom.2016.10.006","volume":"13","author":"AE Ngono","year":"2016","unstructured":"Ngono AE, Chen H-W, Tang WW, Joo Y, King K, Weiskopf D, Sidney J, Sette A, Shresta S (2016) Protective role of cross-reactive CD8 T cells against dengue virus infection. EBioMedicine 13:284\u2013293. https:\/\/doi.org\/10.1016\/j.ebiom.2016.10.006","journal-title":"EBioMedicine"},{"key":"294_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696755","volume":"12","author":"HD Nguyen","year":"2021","unstructured":"Nguyen HD, Chaudhury S, Waickman AT, Friberg H, Currier JR, Wallqvist A (2021) Stochastic model of the adaptive immune response predicts disease severity and captures enhanced cross-reactivity in natural dengue infections. Front Immunol 12:696755. https:\/\/doi.org\/10.3389\/fimmu.2021.696755","journal-title":"Front Immunol"},{"key":"294_CR71","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/imammb\/dqx002","volume":"35","author":"R Nikin-Beers","year":"2018","unstructured":"Nikin-Beers R, Ciupe SM (2018) Modelling original antigenic sin in dengue viral infection. Math Med Biol J IMA 35:257\u2013272. https:\/\/doi.org\/10.1093\/imammb\/dqx002","journal-title":"Math Med Biol J IMA"},{"key":"294_CR72","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S1473-3099(24)00376-1","volume":"24","author":"ML Nogueira","year":"2024","unstructured":"Nogueira ML, Cintra MAT, Moreira JA, Pati\u00f1o EG, Braga PE, Ten\u00f3rio JCV et al (2024) Efficacy and safety of Butantan-DV in participants aged 2\u201359 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil. Lancet Infect Dis 24:1234\u20131244. https:\/\/doi.org\/10.1016\/S1473-3099(24)00376-1","journal-title":"Lancet Infect Dis"},{"key":"294_CR73","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/jit273","volume":"208","author":"S Olkowski","year":"2013","unstructured":"Olkowski S, Forshey BM, Morrison AC, Rocha C, Vilcarromero S, Halsey ES, Kochel TJ, Scott TW, Stoddard ST (2013) Reduced risk of disease during postsecondary dengue virus infections. J Infect Dis 208:1026\u20131033. https:\/\/doi.org\/10.1093\/infdis\/jit273","journal-title":"J Infect Dis"},{"key":"294_CR74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1586\/14760584.2016.1128328","volume":"15","author":"JE Osorio","year":"2016","unstructured":"Osorio JE, Wallace D, Stinchcomb DT (2016) A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone. Expert Rev Vaccines 15:497\u2013508. https:\/\/doi.org\/10.1586\/14760584.2016.1128328","journal-title":"Expert Rev Vaccines"},{"key":"294_CR75","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijid.2021.09.009","volume":"112","author":"SS Pereira","year":"2021","unstructured":"Pereira SS, Andreata-Santos R, Pereira LR, Soares CP, F\u00e9lix AC et al (2021) NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus. Int J Infect Dis 112:202\u2013204. https:\/\/doi.org\/10.1016\/j.ijid.2021.09.009","journal-title":"Int J Infect Dis"},{"key":"294_CR76","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/v16071098","volume":"16","author":"A Posadas-Mondrag\u00f3n","year":"2024","unstructured":"Posadas-Mondrag\u00f3n A, Santiago-Cruz JA, P\u00e9rez-Ju\u00e1rez A, Herrera-Gonz\u00e1lez NE, Sosa-Delgado SM, Wong-Ar\u00e1mbula CE, Rodr\u00edguez-Maldonado AP, V\u00e1zquez-Pichardo M, Duran-Ayala D, Aguilar-Faisal JL (2024) Cross-neutralizing anti-chikungunya and anti-dengue 2 IgG antibodies from patients and BALB\/c mice against dengue and chikungunya viruses. Viruses 16:1098. https:\/\/doi.org\/10.3390\/v16071098","journal-title":"Viruses"},{"key":"294_CR77","doi-asserted-by":"publisher","first-page":"7852","DOI":"10.1073\/pnas.1607931113","volume":"113","author":"L Priyamvada","year":"2016","unstructured":"Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, Pattanapanyasat K, Chokephaibulkit K, Mulligan MJ, Wilson PC, Ahmed R, Suthar MS, Wrammert J (2016) Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci USA 113:7852\u20137857. https:\/\/doi.org\/10.1073\/pnas.1607931113","journal-title":"Proc Natl Acad Sci USA"},{"key":"294_CR78","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1002\/jmv.27826","volume":"94","author":"L Qiu","year":"2022","unstructured":"Qiu L, Huang X, Luo J, Zhao Y, Hong S, Wang X, Feng K, Pan Y, Sun Q (2022) Secondary cross infection with dengue virus serotype 2\/3 aggravates vascular leakage in BALB\/c mice. J Med Virol 94:4338\u20134347. https:\/\/doi.org\/10.1002\/jmv.27826","journal-title":"J Med Virol"},{"key":"294_CR79","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1016\/j.vaccine.2014.03.093","volume":"32","author":"BR Quinan","year":"2014","unstructured":"Quinan BR, Flesch IEA, Pinho TMG, Coelho FM, Tscharke DC, da Fonseca FG (2014) An intact signal peptide on dengue virus E protein enhances immunogenicity for CD8+ T cells and antibody when expressed from modified vaccinia Ankara. Vaccine 32:2972\u20132979. https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.093","journal-title":"Vaccine"},{"key":"294_CR80","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/JVI.02675-12","volume":"87","author":"L Rivino","year":"2013","unstructured":"Rivino L, Kumaran EAP, Jovanovic V, Nadua K, Teo EW, Pang SW, Teo GH, Gan VCH, Lye DC, Leo YS, Hanson BJ, Smith KGC, Bertoletti A, Kemeny DM, MacAry PA (2013) Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection. J Virol 87:2693\u20132706. https:\/\/doi.org\/10.1128\/JVI.02675-12","journal-title":"J Virol"},{"key":"294_CR81","doi-asserted-by":"publisher","first-page":"9760","DOI":"10.1128\/JVI.01051-10","volume":"84","author":"JR Rodriguez-Madoz","year":"2010","unstructured":"Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, Ashour J, Ayllon J, Fernandez-Sesma A (2010) Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol 84:9760\u20139774. https:\/\/doi.org\/10.1128\/JVI.01051-10","journal-title":"J Virol"},{"key":"294_CR82","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri3014","volume":"11","author":"AL Rothman","year":"2011","unstructured":"Rothman AL (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11:532\u2013543. https:\/\/doi.org\/10.1038\/nri3014","journal-title":"Nat Rev Immunol"},{"key":"294_CR83","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","volume":"380","author":"A Sabchareon","year":"2012","unstructured":"Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Wartel TA, Moureau A, Saville M, Bouckenooghe A, Viviani S, Tornieporth NG, Lang J (2012) Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 380:1559\u20131567. https:\/\/doi.org\/10.1016\/S0140-6736(12)61428-7","journal-title":"Lancet"},{"key":"294_CR84","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Vargas LA, Kounlavouth S, Smith ML, Anderson KB, Srikiatkhachorn A, Ellison DW, Currier JR, Endy TP, Mathew A, Rothman AL (2019) Longitudinal analysis of memory B and T cell responses to dengue virus in a 5-year prospective cohort study in Thailand. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.01359","DOI":"10.3389\/fimmu.2019.01359"},{"key":"294_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.710300","volume":"12","author":"LA Sanchez-Vargas","year":"2021","unstructured":"Sanchez-Vargas LA, Anderson KB, Srikiatkhachorn A, Currier JR, Friberg H, Endy TP, Fernandez S, Mathew A, Rothman AL (2021) Longitudinal analysis of dengue virus\u2013specific memory T cell responses and their association with clinical outcome in subsequent DENV infection. Front Immunol 12:710300. https:\/\/doi.org\/10.3389\/fimmu.2021.710300","journal-title":"Front Immunol"},{"key":"294_CR86","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S1473-3099(20)30601-0","volume":"21","author":"S Sangkaew","year":"2021","unstructured":"Sangkaew S, Ming D, Boonyasiri A, Honeyford K, Kalayanarooj S, Yacoub S, Dorigatti I, Holmes A (2021) Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis. Lancet Infect Dis 21:1014\u20131026. https:\/\/doi.org\/10.1016\/S1473-3099(20)30601-0","journal-title":"Lancet Infect Dis"},{"key":"294_CR87","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41467-024-45806-x","volume":"15","author":"A Santos-Peral","year":"2024","unstructured":"Santos-Peral A, Luppa F, Goresch S, Nikolova E, Zaucha M, Lehmann L, Dahlstroem F, Karimzadeh H, Thorn-Seshold J, Winheim E, Schuster E-M, Dobler G, Hoelscher M, K\u00fcmmerer BM, Endres S, Schober K, Krug AB, Pritsch M, Barba-Spaeth G, Rothenfusser S (2024) Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. Nat Commun 15:1696. https:\/\/doi.org\/10.1038\/s41467-024-45806-x","journal-title":"Nat Commun"},{"key":"294_CR88","doi-asserted-by":"publisher","unstructured":"Sarker A, Dhama N, Gupta RD (2023) Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1200195","DOI":"10.3389\/fimmu.2023.1200195"},{"key":"294_CR89","doi-asserted-by":"publisher","first-page":"e00132","DOI":"10.1128\/JVI.00132-21","volume":"95","author":"B Schouest","year":"2021","unstructured":"Schouest B, Grifoni A, Pham J, Mateus J, Sydney J, Brien JD, De Silva AD, Balmaseda A, Harris E, Sette A, Weiskopf D (2021) Pre-existing T cell memory against Zika virus. J Virol 95:e00132\u2013e00121. https:\/\/doi.org\/10.1128\/JVI.00132-21","journal-title":"J Virol"},{"key":"294_CR90","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jmii.2024.07.004","volume":"57","author":"H-I Shih","year":"2024","unstructured":"Shih H-I, Wang Y-C, Wang Y-P, Chi C-Y, Chien Y-W (2024) Risk of severe dengue during secondary infection: A population-based cohort study in Taiwan. J Microbiol Immunol Infect 57:730\u2013738. https:\/\/doi.org\/10.1016\/j.jmii.2024.07.004","journal-title":"J Microbiol Immunol Infect"},{"key":"294_CR91","doi-asserted-by":"publisher","unstructured":"Shukla R, Ramasamy V, Shanmugam RK, Ahuja R, Khanna N (2020) Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine. Front Cell Infect Microbiol 10. https:\/\/doi.org\/10.3389\/fcimb.2020.572681","DOI":"10.3389\/fcimb.2020.572681"},{"key":"294_CR92","doi-asserted-by":"publisher","first-page":"e02181","DOI":"10.1128\/JVI.02181-17","volume":"92","author":"GF Silveira","year":"2018","unstructured":"Silveira GF, Wowk PF, Cataneo AHD, Dos Santos PF, Delgobo M, Stimamiglio MA, Lo Sarzi M, Thomazelli APFS, Conchon-Costa I, Pavanelli WR, Antonelli LRV, B\u00e1fica A, Mansur DS, Dos Santos CND, Bordignon J (2018) Human T lymphocytes are permissive for dengue virus replication. J Virol 92:e02181\u2013e02117. https:\/\/doi.org\/10.1128\/JVI.02181-17","journal-title":"J Virol"},{"key":"294_CR93","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1086\/519170","volume":"196","author":"CP Simmons","year":"2007","unstructured":"Simmons CP, Chau TNB, Thuy TT, Tuan NM, Hoang DM, Thien NT, Lien LB, Quy NT, Hieu NT, Hien TT, McElnea C, Young P, Whitehead S, Hung NT, Farrar J (2007) Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis 196:416\u2013424. https:\/\/doi.org\/10.1086\/519170","journal-title":"J Infect Dis"},{"key":"294_CR94","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1056\/NEJMra1110265","volume":"366","author":"CP Simmons","year":"2012","unstructured":"Simmons CP, Farrar JJ et al (2012) Dengue. N Engl J Med 366:1423\u20131432. https:\/\/doi.org\/10.1056\/NEJMra1110265","journal-title":"N Engl J Med"},{"key":"294_CR95","doi-asserted-by":"publisher","first-page":"e1214","DOI":"10.1093\/infdis\/jiae222","volume":"230","author":"C Sirivichayakul","year":"2024","unstructured":"Sirivichayakul C et al (2024) Efficacy and safety of a tetravalent dengue vaccine (TAK-003) in children with prior japanese encephalitis or yellow fever vaccination. J Infect Dis 230:e1214\u2013e1225. https:\/\/doi.org\/10.1093\/infdis\/jiae222","journal-title":"J Infect Dis"},{"key":"294_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154760","volume":"11","author":"K-M Soo","year":"2016","unstructured":"Soo K-M, Khalid B, Ching S-M, Chee H-Y (2016) Meta-analysis of dengue severity during infection by different dengue virus serotypes in primary and secondary infections. PLoS One 11:e0154760. https:\/\/doi.org\/10.1371\/journal.pone.0154760","journal-title":"PLoS One"},{"key":"294_CR97","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijid.2019.01.023","volume":"81","author":"NCS Souza","year":"2019","unstructured":"Souza NCS et al (2019) Evaluation of serological cross-reactivity between yellow fever and other flaviviruses. Int J Infect Dis 81:4\u20135. https:\/\/doi.org\/10.1016\/j.ijid.2019.01.023","journal-title":"Int J Infect Dis"},{"key":"294_CR98","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","volume":"379","author":"S Sridhar","year":"2018","unstructured":"Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, Savarino S, Zambrano B, Moureau A, Khromava A, Moodie Z, Westling T, Mascare\u00f1as C, Frago C, Cort\u00e9s M, Chansinghakul D, Noriega F, Bouckenooghe A, Chen J, Ng S-P, Gilbert PB, Gurunathan S, DiazGranados CA (2018) Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med 379:327\u2013340. https:\/\/doi.org\/10.1056\/NEJMoa1800820","journal-title":"N Engl J Med"},{"key":"294_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051335","volume":"7","author":"A Srikiatkhachorn","year":"2012","unstructured":"Srikiatkhachorn A, Wichit S, Gibbons RV, Green S, Libraty DH, Endy TP, Ennis FA, Kalayanarooj S, Rothman AL (2012) Dengue viral RNA levels in peripheral blood mononuclear cells are associated with disease severity and preexisting dengue immune status. PLoS One 7:e51335. https:\/\/doi.org\/10.1371\/journal.pone.0051335","journal-title":"PLoS One"},{"key":"294_CR100","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41577-019-0123-x","volume":"19","author":"AL St. John","year":"2019","unstructured":"St. John AL, Rathore APS (2019) Adaptive immune responses to primary and secondary dengue virus infections. Nat Rev Immunol 19:218\u2013230. https:\/\/doi.org\/10.1038\/s41577-019-0123-x","journal-title":"Nat Rev Immunol"},{"key":"294_CR101","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D (2016) Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353:823\u2013826. https:\/\/doi.org\/10.1126\/science.aaf8505","journal-title":"Science"},{"key":"294_CR102","doi-asserted-by":"publisher","unstructured":"Subramaniam KS, Lant S, Goodwin L, Grifoni A, Weiskopf D, Turtle L (2020) Two is better than one: evidence for T-cell cross-protection between dengue and Zika and implications on vaccine design. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.00517","DOI":"10.3389\/fimmu.2020.00517"},{"key":"294_CR103","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01123-16","volume":"7","author":"JA Swanstrom","year":"2016","unstructured":"Swanstrom JA, Plante JA, Plante KS, Young EF, McGowan E, Gallichotte EN, Widman DG, Heise MT, de Silva AM, Baric RS (2016) Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. MBio 7:10-1128","journal-title":"MBio"},{"key":"294_CR104","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ebiom.2017.04.033","volume":"20","author":"LB Talarico","year":"2017","unstructured":"Talarico LB, Batalle JP, Byrne AB, Brahamian JM, Ferretti A, Garc\u00eda AG, Mauri A, Simonetto C, Hijano DR, Lawrence A, Acosta PL, Caballero MT, Paredes Rojas Y, Iba\u00f1ez LI, Melendi GA, Rey FA, Damonte EB, Harris E, Polack FP (2017) The role of heterotypic DENV-specific CD8+T lymphocytes in an immunocompetent mouse model of secondary dengue virus infection. EBioMedicine 20:202\u2013216. https:\/\/doi.org\/10.1016\/j.ebiom.2017.04.033","journal-title":"EBioMedicine"},{"key":"294_CR105","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/22221751.2021.2021808","volume":"11","author":"T Tamura","year":"2022","unstructured":"Tamura T, Zhang J, Madan V, Biswas A, Schwoerer MP, Cafiero TR, Heller BL, Wang W, Ploss A (2022) Generation and characterization of genetically and antigenically diverse infectious clones of dengue virus serotypes 1\u20134. Emerg Microbes Infect 11:227\u2013239. https:\/\/doi.org\/10.1080\/22221751.2021.2021808","journal-title":"Emerg Microbes Infect"},{"key":"294_CR106","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.vaccine.2022.01.016","volume":"40","author":"V Tricou","year":"2022","unstructured":"Tricou V, Gottardo R, Egan MA, Clement F, Leroux-Roels G, S\u00e1ez-Llorens X, Borkowski A, Wallace D, Dean HJ (2022) Characterization of the cell-mediated immune response to Takeda\u2019s live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting. Vaccine 40:1143\u20131151. https:\/\/doi.org\/10.1016\/j.vaccine.2022.01.016","journal-title":"Vaccine"},{"key":"294_CR107","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/eji.200839108","volume":"40","author":"DW Trobaugh","year":"2010","unstructured":"Trobaugh DW, Yang L, Ennis FA, Green S (2010) Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses. Eur J Immunol 40:1315\u20131327. https:\/\/doi.org\/10.1002\/eji.200839108","journal-title":"Eur J Immunol"},{"key":"294_CR108","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s40249-021-00908-2","volume":"10","author":"T Tsheten","year":"2021","unstructured":"Tsheten T, Clements ACA, Gray DJ, Adhikary RK, Furuya-Kanamori L, Wangdi K (2021) Clinical predictors of severe dengue: a systematic review and meta-analysis. Infect Dis Poverty 10:123. https:\/\/doi.org\/10.1186\/s40249-021-00908-2","journal-title":"Infect Dis Poverty"},{"key":"294_CR109","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcv.2017.05.001","volume":"92","author":"MPA van Meer","year":"2017","unstructured":"van Meer MPA, M\u00f6gling R, Klaasse J, Chandler FD, Pas SD, van der Eijk AA, Koopmans MPG, Reusken CBEM, GeurtsvanKessel CH (2017) Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence. J Clin Virol 92:25\u201331. https:\/\/doi.org\/10.1016\/j.jcv.2017.05.001","journal-title":"J Clin Virol"},{"key":"294_CR110","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/cid\/ciw589","volume":"63","author":"JJ Waggoner","year":"2016","unstructured":"Waggoner JJ, Gresh L, Vargas MJ, Ballesteros G, Tellez Y, Soda KJ, Sahoo MK, Nu\u00f1ez A, Balmaseda A, Harris E, Pinsky BA (2016) Viremia and clinical presentation in Nicaraguan patients infected with Zika virus, chikungunya virus, and dengue virus. Clin Infect Dis 63:1584\u20131590. https:\/\/doi.org\/10.1093\/cid\/ciw589","journal-title":"Clin Infect Dis"},{"key":"294_CR111","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1128\/JVI.00216-15","volume":"89","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, Chan KWK, Wang J, Rivino L, Lok S-M, Vasudevan SG (2015) Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice. J Virol 89:5847\u20135861. https:\/\/doi.org\/10.1128\/JVI.00216-15","journal-title":"J Virol"},{"key":"294_CR112","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/infdis\/jiy482","volume":"219","author":"S Watanabe","year":"2019","unstructured":"Watanabe S, Tan NWW, Chan KWK, Vasudevan SG (2019) Dengue virus and Zika virus serological cross-reactivity and their impact on pathogenesis in mice. J Infect Dis 219:223\u2013233. https:\/\/doi.org\/10.1093\/infdis\/jiy482","journal-title":"J Infect Dis"},{"key":"294_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777672","volume":"12","author":"AD Wegman","year":"2021","unstructured":"Wegman AD, Fang H, Rothman AL, Thomas SJ, Endy TP, McCracken MK, Currier JR, Friberg H, Gromowski GD, Waickman AT (2021) Monomeric IgA antagonizes IgG-mediated enhancement of DENV infection. Front Immunol 12:777672. https:\/\/doi.org\/10.3389\/fimmu.2021.777672","journal-title":"Front Immunol"},{"key":"294_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011616","volume":"19","author":"AD Wegman","year":"2023","unstructured":"Wegman AD, Waldran MJ, Bahr LE, Lu JQ, Baxter KE, Thomas SJ, Waickman AT (2023) DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection. PLoS Pathog 19:e1011616. https:\/\/doi.org\/10.1371\/journal.ppat.1011616","journal-title":"PLoS Pathog"},{"key":"294_CR115","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","volume":"110","author":"D Weiskopf","year":"2013","unstructured":"Weiskopf D, Angelo MA, de Azeredo EL, Sidney J, Greenbaum JA, Fernando AN, Broadwater A, Kolla RV, De Silva AD, de Silva AM, Mattia KA, Doranz BJ, Grey HM, Shresta S, Peters B, Sette A (2013) Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci 110:E2046\u2013E2053. https:\/\/doi.org\/10.1073\/pnas.1305227110","journal-title":"Proc Natl Acad Sci"},{"key":"294_CR116","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/jir.2017.0106","volume":"37","author":"J Wen","year":"2017","unstructured":"Wen J, Shresta S (2017) T cell immunity to Zika and dengue viral infections. J Interf Cytokine Res 37:475\u2013479. https:\/\/doi.org\/10.1089\/jir.2017.0106","journal-title":"J Interf Cytokine Res"},{"key":"294_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2019.02.001","volume":"59","author":"J Wen","year":"2019","unstructured":"Wen J, Shresta S (2019) Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine? Curr Opin Immunol 59:1\u20138. https:\/\/doi.org\/10.1016\/j.coi.2019.02.001","journal-title":"Curr Opin Immunol"},{"key":"294_CR118","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1586\/14760584.2016.1115727","volume":"15","author":"SS Whitehead","year":"2016","unstructured":"Whitehead SS (2016) Development of TV003\/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD\u2122 vaccine? Expert Rev Vaccines 15:509\u2013517. https:\/\/doi.org\/10.1586\/14760584.2016.1115727","journal-title":"Expert Rev Vaccines"},{"key":"294_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011923","volume":"18","author":"L Xu","year":"2024","unstructured":"Xu L, Li M, Zhang J, Li D, Tao J, Zhang F, Jin X, Lu J, Liu T (2024) Metabolomic landscape of macrophage discloses an anabolic signature of dengue virus infection and antibody-dependent enhancement of viral infection. PLoS Negl Trop Dis 18:e0011923. https:\/\/doi.org\/10.1371\/journal.pntd.0011923","journal-title":"PLoS Negl Trop Dis"},{"key":"294_CR120","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41564-023-01421-y","volume":"8","author":"R Yamin","year":"2023","unstructured":"Yamin R, Kao KS, MacDonald MR, Cantaert T, Rice CM, Ravetch JV, Bournazos S (2023) Human Fc\u03b3RIIIa activation on splenic macrophages drives dengue pathogenesis in mice. Nat Microbiol 8:1468\u20131479. https:\/\/doi.org\/10.1038\/s41564-023-01421-y","journal-title":"Nat Microbiol"},{"key":"294_CR121","doi-asserted-by":"publisher","first-page":"eadn2199","DOI":"10.1126\/scitranslmed.adn2199","volume":"16","author":"JV Zambrana","year":"2024","unstructured":"Zambrana JV, Hasund CM, Aogo RA, Bos S, Arguello S, Gonzalez K, Collado D, Miranda T, Kuan G, Gordon A, Balmaseda A, Katzelnick LC, Harris E (2024) Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1. Sci Transl Med 16:eadn2199. https:\/\/doi.org\/10.1126\/scitranslmed.adn2199","journal-title":"Sci Transl Med"},{"key":"294_CR122","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","volume":"7","author":"RM Zellweger","year":"2010","unstructured":"Zellweger RM, Prestwood TR, Shresta S (2010) Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7:128\u2013139. https:\/\/doi.org\/10.1016\/j.chom.2010.01.004","journal-title":"Cell Host Microbe"},{"key":"294_CR123","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1128\/JVI.00036-15","volume":"89","author":"RM Zellweger","year":"2015","unstructured":"Zellweger RM, Tang WW, Eddy WE, King K, Sanchez MC, Shresta S (2015) CD8+ T cells can mediate short-term protection against heterotypic dengue virus reinfection in mice. J Virol 89:6494\u20136505. https:\/\/doi.org\/10.1128\/JVI.00036-15","journal-title":"J Virol"},{"key":"294_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.197882","volume":"278","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Chen D, Yang L, Zou W, Duan Z, Zhang Y, Wen J (2020) Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model. Virus Res 278:197882. https:\/\/doi.org\/10.1016\/j.virusres.2020.197882","journal-title":"Virus Res"}],"updated-by":[{"DOI":"10.1007\/82_2025_323","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000}}],"container-title":["Current Topics in Microbiology and Immunology","Dengue Virus Evolution: From Emergence to a Global Health Crisis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:17:19Z","timestamp":1767313039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783032099808","9783032099815"],"references-count":126,"URL":"https:\/\/doi.org\/10.1007\/82_2025_294","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"14 May 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"30 July 2025","order":2,"name":"change_date","label":"Change Date","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"A correction has been published.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}